One of the most interesting things about atrial fibrillation is how geography—the location where you grew up, where you live now, and even where you visit—can affect your risk of atrial fibrillation and stroke. A fascinating map from the CDC (the Centers for Disease Control and Prevention) dramatically illustrates which parts of the country had …
Read More
Recently, Mellanie True Hills had the opportunity to visit with The Honorable William H. Frist, MD, Former US Senate Majority Leader, heart and lung transplant surgeon, and AF Stat Policy Advisor. Dr. Frist took a moment to record an overview of the importance of AF Stat for afib patients and …
Read More
In this video from Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Natale discusses new directions in afib treatment, including hybrid procedures combining catheter ablation and surgery for chronic or persistent atrial fibrillation, and contact force sensing for determining the force applied during catheter ablation. Dr. Natale is the Executive Medical …
Read More
In this video from Boston Atrial Fibrillation Symposium 2010, Professor John Camm discusses the two newest antiarrhythmic drugs, dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away. These antiarrhythmic (rhythm control) drugs help to put patients …
Read More
In this video from Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy discusses some of the new atrial fibrillation catheter ablation technologies and also talks about non-pharmacological approaches to stroke prevention in afib, such as the Watchman and Lariat suture. Dr. Reddy is the Director of Electrophysiology at Mount Sinai …
Read More
In part 2 of our video interview with Dr. Riccardo Cappato at Boston Atrial Fibrillation Symposium 2010, he discusses atrial fibrillation and its impact and treatment for athletes. Dr. Cappato is a cardiologist and Chief of the Arrhythmia and Electrophysiology Department at the Center of Clinical Arrhythmia and Electrophysiology at …
Read More
In part 1 of our video interview with Dr. Riccardo Cappato at Boston Atrial Fibrillation Symposium 2010, he discusses the results of the Second Worldwide Survey on AF Ablation. Dr. Cappato is a cardiologist and Chief of the Arrhythmia and Electrophysiology Department at the Center of Clinical Arrhythmia and Electrophysiology …
Read More
In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talks about gender differences in atrial fibrillation treatment and afib stroke risk in women. Dr. Russo is Director of Cardiac Ablation and Arrhythmia Services at Cooper University Hospital (New Jersey) and professor of medicine at Robert Wood …
Read More
One of the most common questions we get centers around the use of anticoagulant drugs—either the brand drug, Coumadin, or the generic version, warfarin—and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It's just as …
Read More
There was an update today on the long-awaited FDA status of Atritech's WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced …
Read More